HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 8 Hours

×
3 articles summarized · Last updated: LATEST

Last updated: September 21, 2026, 10:03 PM ET

Private Equity

Telix Pharmaceuticals has agreed to acquire BlackRock-backed ITM for up to $2.35bn, paying $1.65bn in cash upfront for 100% of the radiopharma group's shares in a merger that consolidates two players in targeted cancer therapy.

Healthcare Deals

Veridian, backed by HealthEdge, closed its acquisition of the Scar Science brand from Mitchell-Vance Laboratories, deepening its scar and wound-care footprint.

Venture

Tech Crunch Disrupt 2026 passes are discounted by up to $200 with five days remaining, plus 50% off for select attendees.